|
2007
|
Invention
|
Novel aminoguanidines as melanocortin receptor ligands.. There are described compounds of general... |
|
|
Invention
|
Use of a compound as vegf inhibitor. There is disclosed the use of N-(2-chloro-3,4-dimethoxybenzy... |
|
|
Invention
|
Novel amides acting on the adenosine receptors. There are described compounds of formula (I) in w... |
|
2006
|
Invention
|
Methods and pharmaceutical compositions for the treatment of neurological damage.
The invention ... |
|
|
Invention
|
Methods and pharmaceutical compositions for the treatment of neurological damage. The invention r... |
|
|
Invention
|
Methods and pharmaceutical compositions for the treatment of neurological damage.
The ... |
|
2003
|
Invention
|
Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands. The pre... |
|
2001
|
Invention
|
Pharmaceutical composition and method for the treatment of neoplastic cells. A pharmaceutical com... |
